GAIA BioMedicine

Fukuoka, Japan · Founded 2015 · Privately Held (backing)

Operator of a biopharmaceutical company intended to deliver cancer immuno-cell therapy. GAIA BioMedicine is based in Fukuoka, Japan and was founded in 2015. Its last reported valuation was $88.4 million in Jul 2025. It has raised $37.6 million.

Last reported valuation
$88.4M
Oct 2026
Priced at
—
Total raised
$37.6M
Last round
—

Who backs GAIA BioMedicine?

10 investors
InvestorType
Mitsubishi UFJ CapitalOther
SBI InvestmentVenture capital
JIC Venture Growth InvestmentsVenture capital
UntroDOther
Osaka University Venture CapitalVenture capital
CEJ Capital—
Hisamitsu Pharmaceutical—
Japan Agency for Medical Research and Development—
QB Capital—
Taiho Innovations—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

GAIA BioMedicine investors

10 investors are on record for GAIA BioMedicine, including Mitsubishi UFJ Capital, SBI Investment, JIC Venture Growth Investments and UntroD.

Private Market View
More of GAIA BioMedicine with a free Private Market View account
  • ·Watch GAIA BioMedicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like GAIA BioMedicine. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View